Industry Presentations
Treatment Option for CML
Presentations
A Treatment Option for Adult Patients With Newly Diagnosed CP Ph+ CML or Patients With CML Resistant/Intolerant to Prior TKI Therapy
Speakers: Jorge Cortes, MD Duration: 50 minutes
Presented on: January 19, 2021
*This session is not eligible for AMA PRA Category 1 CreditsTM
Speakers